Cisplatin upregulates Saccharomyces cerevisiae genes involved in iron homeostasis through activation of the iron insufficiency-responsive transcription factor Aft1

Journal of Cellular Physiology

Volumn 210, Issue 2, 2007, Pages 378-384

  Kimura, Akiko ^a   Ohashi, Kazuaki ^a,b   Naganuma, Akira ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BATHOPHENANTHROLINE SULFONATE; CISPLATIN; COMPLEMENTARY DNA; FERROUS ION; IRON; IRON 55; PROTEIN AFT1; SULFONIC ACID DERIVATIVE; TRANSCRIPTION FACTOR;

ARTICLE; BINDING SITE; CONTROLLED STUDY; DNA MICROARRAY; DRUG MECHANISM; DRUG RESPONSE; FET3 GENE; FUNCTIONAL PROTEOMICS; FUNGAL GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE TARGETING; GENOMICS; IRON BALANCE; IRON DEFICIENCY; IRON TRANSPORT; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN DNA BINDING; PROTEIN DNA INTERACTION; PROTEIN DOMAIN; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SACCHAROMYCES CEREVISIAE; TRANSCRIPTION INITIATION; UPREGULATION; YEAST CELL;

ANTINEOPLASTIC AGENTS; BINDING SITES; CERULOPLASMIN; CISPLATIN; GENE EXPRESSION REGULATION, FUNGAL; HOMEOSTASIS; IRON; LAC OPERON; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENANTHROLINES; PROMOTER REGIONS (GENETICS); PROTEIN STRUCTURE, TERTIARY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; TRANSCRIPTION FACTORS; UP-REGULATION;

SACCHAROMYCES CEREVISIAE;

EID: 33845619104     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20845     Document Type: Article

References (49)

1. Aebi S, Kurdi-Haidar B, Gordon R, Cenni B, Zheng H, Fink D, Christen RD, Boland CR, Koi M, Fishel R, Howell SB. 1996. Loss of DNA mismatch repair in acquired resistance to cisplatin. Cancer Res 56:3087-3090.
2. Alcain FJ, Low H, Crane FL. 1994. Iron reverses impermeable chelator inhibition of DNA synthesis in CCl 39 cells. Proc Natl Acad Sci USA 91:7903-7906.
3. Askwith C, Eide D, Van Ho A, Bernard PS, Li L, Davis-Kaplan S, Sipe DM, Kaplan J. 1994. The FET3 gene of S. cerevisiae encodes a multicopper oxidase required for ferrous iron uptake. Cell 76:403-410.
4. Auclair K, Huang HW, Moenne-Loccoz P, Ortiz de Montellano PR. 2003. Cloning and expression of a heme binding protein from the genome of Saccharomyces cerevisiae. Protein Expr Purif 28:340-349.
5. Birrell GW, Brown JA, Wu HI, Giaever G, Chu AM, Davis RW, Brown JM. 2002. Transcriptional response of Saccharomyces cerevisiae to DNA-damaging agents does not identify the genes that protect against these agents. Proc Natl Acad Sci USA 99:8778-8783.
6. Bose RN. 2002. Biomolecular targets for platinum antitumor drugs. Mini Rev Med Chem 2:103-111.
7. Brown SJ, Kellett PJ, Lippard SJ. 1993. Ixr1, a yeast protein that binds to platinated DNA and confers sensitivity to cisplatin. Science 261:603-605.
8. Dancis A, Klausner RD, Hinnebusch AG, Barriocanal JG. 1990. Genetic evidence that ferric reductase is required for iron uptake in Saccharomyces cerevisiae. Mol Cell Biol 10:2294-2301.
9. De Freitas J, Wintz H, Kim JH, Poynton H, Fox T, Vulpe C. 2003. Yeast, a model organism for iron and copper metabolism studies. Biometals 16:185-197.
10. Dix DR, Bridgham JT, Broderius MA, Byersdorfer CA, Eide DJ. 1994. The FET4 gene encodes the low affinity Fe(II) transport protein of Saccharomyces cerevisiae. J Biol Chem 269:26092-26099.
11. Einhorn LH, Williams SD. 1979. The role of cis-platinum in solid-tumor therapy. N Engl J Med 300:289-291.
12. Fink D, Zheng H, Nebel S, Norris PS, Aebi S, Lin TP, Nehme A, Christen RD, Haas M, MacLeod CL, Howell SB. 1997. In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair. Cancer Res 57:1841-1845.
13. Fox ME, Feldman BJ, Chu G. 1994. A novel role for DNA photolyase: Binding to DNA damaged by drugs is associated with enhanced cytotoxicity in Saccharomyces cerevisiae. Mol Cell Biol 14:8071-8077.
14. Fu D, Beeler TJ, Dunn TM. 1995. Sequence, mapping and disruption of CCC2, a gene that cross-complements the Ca(2+)-sensitive phenotype of csg1 mutants and encodes a P-type ATPase belonging to the Cu(2+)-ATPase subfamily. Yeast 11:283-292.
15. Fujii R, Mutoh M, Niwa K, Yamada K, Aikou T, Nakagawa M, Kuwano M, Akiyama S. 1994. Active efflux system for cisplatin in cisplatin-resistant human KB cells. Jpn J Cancer Res 85:426-433.
16. Furuchi T, Ishikawa H, Miura N, Ishizuka M, Kajiya K, Kuge S, Naganuma A. 2001. Two nuclear proteins, Cin5 and Ydr259c, that confer resistance to cisplatin in Saccharomyces cerevisiae. Mol Pharmacol 59:470-474.
17. Furuchi T, Hwang GW, Naganuma A. 2002. Overexpression of the ubiquitin-conjugating enzyme Cdc34 confers resistance to methylmercury in Saccharomyces cerevisiae. Mol Pharmacol 61:738-741.
18. Gately DP, Howell SB. 1993. Cellular accumulation of the anticancer agent cisplatin: A review. Br J Cancer 67:1171-1176.
19. Gatti L, Chen D, Beretta GL, Rustici G, Carenini N, Corna E, Colangelo D, Zunino F, Bahler J, Perego P. 2004. Global gene expression of fission yeast in response to cisplatin. Cell Mol Life Sci 61:2253-2263.
20. Georgatsou E, Alexandraki D. 1994. Two distinctly regulated genes are required for ferric reduction, the first step of iron uptake in Saccharomyces cerevisiae. Mol Cell Biol 14:3065-3073.
21. Godwin AK, Meister A, O'Dwyer PJ, Huang CS, Hamilton TC, Anderson ME. 1992. High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc Natl Acad Sci USA 89:3070-3074.
22. Heymann P, Ernst JF, Winkelmann G. 1999. Identification of a fungal triacetylfusarinine C siderophore transport gene (TAFl) in Saccharomyces cerevisiae as a member of the major facilitator superfamily. Biometals 12:301-306.
23. Heymann P, Ernst JF, Winkelmann G. 2000. Identification and substrate specificity of a ferrichrome-type siderophore transporter (Arn1p) in Saccharomyces cerevisiae. FEMS Microbiol Lett 186:221-227.
24. Holzer AK, Samimi G, Katano K, Naerdemann W, Lin X, Safaei R, Howell SB. 2004. The copper influx transporter human copper transport protein 1 regulates the uptake of cisplatin in human ovarian carcinoma cells. Mol Pharmacol 66:817-823.
25. Huang RY, Eddy M, Vujcic M, Kowalski D. 2005. Genome-wide screen identifies genes whose inactivation confer resistance to cisplatin in Saccharomyces cerevisiae. Cancer Res 65:5890-5897.
26. Ikeda K, Miura K, Himeno S, Imura N, Naganuma A. 2001. Glutathione content is correlated with the sensitivity of lines of PC12 cells to cisplatin without a corresponding change in the accumulation of platinum. Mol Cell Biochem 219:51-56.
27. Ishida S, Lee J, Thiele DJ, Herskowitz I. 2002. Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals. Proc Natl Acad Sci USA 99:14298-14302.
28. Ishikawa T, Ali-Osman F. 1993. Glutathione-associated cis-diamminedichloroplatinum(II) metabolism and ATP-dependent efflux from leukemia cells. Molecular characterization of glutathione-platinum complex and its biological significance. J Biol Chem 268:20116-20125.
29. Isoyama T, Murayama A, Nomoto A, Kuge S. 2001. Nuclear import of the yeast AP-1-like transcription factor Yap1p is mediated by transport receptor Pse1p, and this import step is not affected by oxidative stress. J Biol Chem 276:21863-21869.
30. Kelley SL, Basu A, Teicher BA, Hacker MP, Hamer DH, Lazo JS. 1988. Overexpression of metallothionein confers resistance to anticancer drugs. Science 241:1813-1815.
31. Kikuchi Y, Iwano I, Miyauchi M, Kita T, Sugita M, Tenjin Y, Nagata I. 1990. Possible mechanisms of resistance to cis-diamminedichloroplatinum (II) of human ovarian cancer cells. Jpn J Cancer Res 81:701-706.
32. Lesuisse E, Simon-Casteras M, Labbe P. 1998. Siderophore-mediated iron uptake in Saccharomyces cerevisiae: The SIT1 gene encodes a ferrioxamine B permease that belongs to the major facilitator superfamily. Microbiology 144: 3455-3462.
33. Martins LJ, Jensen LT, Simon JR, Keller GL, Winge DR. 1998. Metalloregulation of FRE1 and FRE2 homologs in Saccharomyces cerevisiae. J Biol Chem 273: 23716-23721.
34. Mistry P, Loh SY, Kelland LR, Harrap KR. 1993. Effect of buthionine sulfoximine on PtII and PtIV drug accumulation and the formation of glutathione conjugates in human ovarian-carcinoma cell lines. Int J Cancer 55:848-856.
35. Naganuma A, Satoh M, Imura N. 1987. Prevention of lethal and renal toxicity of cis-diamminedichloroplatinum(II) by induction of metallothionein synthesis without compromising its antitumor activity in mice. Cancer Res 47:983-987.
36. Naganuma A, Miura N, Kaneko S, Mishina T, Hosoya S, Miyairi S, Furuchi T, Kuge S. 2000. GFAT as a target molecule of methylmercury toxicity in Saccharomyces cerevisiae. FASEB J 14:968-972.
37. Niedner H, Christen R, Lin X, Kondo A, Howell SB. 2001. Identification of genes that mediate sensitivity to cisplatin. Mol Pharmacol 60:1153-1160.
38. Ohashi K, Kajiya K, Inaba S, Hasegawa T, Seko Y, Furuchi T, Naganuma A. 2003. Copper (II) protects yeast against toxicity of cisplatin independently of induction of metallothionein and inhibition of platinum uptake. Biochem Biophys Res Commun 310:148-152.
39. Pantopoulos K. 2004. Iron metabolism and the IRE/IRP regulatory system: An update. Ann N Y Acad Sci 1012:1-13.
40. Protchenko O, Ferea T, Rashford J, Tiedeman J, Brown PO, Botstein D, Philpott CC. 2001. Three cell wall mannoproteins facilitate the uptake of iron in Saccharomyces cerevisiae. J Biol Chem 276:49244-49250.
41. Puig S, Askeland E, Thiele DJ. 2005. Coordinated remodeling of cellular metabolism during iron deficiency through targeted mRNA degradation. Cell 120:99-110.
42. Safaei R, Howell SB. 2005. Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugs. Crit Rev Oncol Hematol 53:13-23.
43. Schenk PW, Boersma AW, Brandsma JA, den Dulk H, Burger H, Stoter G, Brouwer J, Nooter K. 2001. SKY1 is involved in cisplatin-induced cell kill in Saccharomyces cerevisiae, and inactivation of its human homologue, SRPK1, induces cisplatin resistance in a human ovarian carcinoma cell line. Cancer Res 61:6982-6986.
44. Schenk PW, Brok M, Boersma AW, Brandsma JA, Den Dulk H, Burger H, Stoter G, Brouwer J, Nooter K. 2003. Anticancer drug resistance induced by disruption of the Saccharomyces cerevisiae NPR2 gene: A novel component involved in cisplatin- and doxorubicin-provoked cell kill. Mol Pharmacol 64: 259-268.
45. Siddik ZH. 2003. Cisplatin: Mode of cytotoxic action and molecular basis of resistance. Oncogene 22:7265-7279.
46. Stearman R, Yuan DS, Yamaguchi-Iwai Y, Klausner RD, Dancis A. 1996. A permease-oxidase complex involved in high-affinity iron uptake in yeast. Science 271:1552-1557.
47. Yamaguchi-Iwai Y, Dancis A, Klausner RD. 1995. AFT1: A mediator of iron regulated transcriptional control in Saccharomyces cerevisiae. EMBO J 14: 1231-1239.
48. Yamaguchi-Iwai Y, Stearman R, Dancis A, Klausner RD. 1996. Iron-regulated DNA binding by the AFT1 protein controls the iron regulon in yeast. EMBO J 15:3377-3384.
49. Yamaguchi-Iwai Y, Ueta R, Fukunaka A, Sasaki R. 2002. Subcellular localization of Aft1 transcription factor responds to iron status in Saccharomyces cerevisiae. J Biol Chem 277:18914-18918.